EcoDrugPlus

Ensembl ID : AGAP001459
Gene Symbol: AGA:AGAP_AGAP001459
5 External references
128 Possible Orthologues:

Ensembl ID : AGAP010592
Gene Symbol: AGA:AGAP_AGAP010592
6 External references
92 Possible Orthologues:

Ensembl ID : AGAP007580
Gene Symbol: AGA:AGAP_AGAP007580
5 External references
115 Possible Orthologues:

Ensembl ID : AGAP000655
Gene Symbol: AGA:AGAP_AGAP000655
5 External references
107 Possible Orthologues:

Ensembl ID : AGAP005532
Gene Symbol: AGA:AGAP_AGAP005532
3 External references
933 Possible Orthologues:

26s Proteasome 26s Non-Atpase Subunit N1

Ensembl ID : AGAP002481
Gene Symbol: RPN1
1 External references
77 Possible Orthologues:

40s Ribosomal Protein S23

Ensembl ID : AGAP012990
Gene Symbol: RPS23
3 External references
118 Possible Orthologues:

60s Ribosomal Protein L3

Ensembl ID : AGAP003556
Gene Symbol: RPL3
1 External references
126 Possible Orthologues:

60s Ribosomal Protein L9

Ensembl ID : AGAP009508
Gene Symbol: RPL9
1 External references
200 Possible Orthologues:

Atp-Binding Cassette Transporter (Abc Transporter) Family B Member 2

Ensembl ID : AGAP005639
Gene Symbol: ABCB2
1 External references
873 Possible Orthologues:

Atp-Binding Cassette Transporter (Abc Transporter) Family C Member 14

Ensembl ID : AGAP009835
Gene Symbol: ABCC14
1 External references
136 Possible Orthologues:

Atp-Binding Cassette Transporter (Abc Transporter) Family C Member 4

Ensembl ID : AGAP029457
Gene Symbol: ABCC4
1 External references
149 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).